Cleared Traditional

PacePro Wire (K240864) - FDA 510(k) Clearance

Class II Cardiovascular device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K240864 · Opsens, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 2024
Decision
57d
Days
Class 2
Risk

K240864 is an FDA 510(k) clearance for the PacePro Wire. Classified as Wire, Guide, Catheter (product code DQX), Class II - Special Controls.

Submitted by Opsens, Inc. (Quebec, CA). The FDA issued a Cleared decision on May 24, 2024 after a review of 57 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1330 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Opsens, Inc. devices

Submission Details

510(k) Number K240864 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 28, 2024
Decision Date May 24, 2024
Days to Decision 57 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
68d faster than avg
Panel avg: 125d · This submission: 57d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DQX Wire, Guide, Catheter
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1330
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQX Wire, Guide, Catheter

All 251
Devices cleared under the same product code (DQX) and FDA review panel - the closest regulatory comparables to K240864.
CROSSLEAD Tracker
K241510 · Asahi Intecc Co., Ltd. · Aug 2024
MINAMO blue
K240387 · Asahi Intecc Co., Ltd. · Jun 2024
FMD Peripheral Guide Wire F-18 Flex 400 (CSU415400259)
K240460 · FMD Co., Ltd. · Jun 2024
BNLE Hydrophilic Jacketed Peripheral Guidewire
K232662 · Biomerics Nle · May 2024
Mighty Wire Guide Wire
K230418 · Merit Medical Systems, Inc. · Oct 2023
Steerant™ Super Stiff Guidewire
K232570 · Medtronic Vascular · Oct 2023